Loading
A phase 3 trial of F-MISO (JBS-003) run by Memorial Sloan Kettering Cancer Center, now recruiting.
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer is a phase 3 interventional study registered as NCT06563479 by Memorial Sloan Kettering Cancer Center, with 291 participants planned, started 2024-08-19. Conditions recorded: HPV-Related Squamous Cell Carcinoma. Interventions recorded: FMISO-PET Scan, Chemoradiation, Chemoradiation and Assessments.
Shares F-MISO (JBS-003), Juniper Biosciences, Head and neck squamous cell carcinoma and the tag pipeline.
Shares F-MISO (JBS-003), Juniper Biosciences and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/